SCHEMBL7348279

SCHEMBL7348279

[O]C(=O)c1cc(Cl)c(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.46
HSD17B10 Q99714 5/20 0.46
CYP3A4 P08684 3/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
ALDH1A1 P00352 3/20 0.43
TTR P02766 1/20 0.42
TSHR P16473 6/20 0.41
CASP1 P29466 2/20 0.39
HSP90AA1 P07900 1/20 0.36
MAPK1 P28482 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
SRD5A2 P31213 1/20 0.35
AHR P35869 3/20 0.35
TPMT P51580 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328541 0.80 HPGD (0.48) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL983196 0.78 HPGD (0.46) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL7263572 0.78 TTR (0.68) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL3130004 0.76 LMNA (0.47) HPGDHSD17B10CYP3A4CRHBPCRHR2
Fluoride SCHEMBL27668632 0.76 TTR (0.65) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL7495444 0.76 HPGD (0.43) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL2967888 0.76 HPGD (0.43) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL7779178 0.76 CA5A (0.50) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL11048208 0.76 HPGD (0.43) HPGDHSD17B10CYP3A4CRHBPCRHR2
SCHEMBL2170895 0.74 TPMT (0.62) TTRTSHRTPMTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5985869-A USEFUL AS VASODILATORS, HYPOTENSIVE AGENTS, WATER DIURETICS, PLATELET AGGLUTINATION INHIBITORS OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-11-16 US disclosed
US-5753677-A Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-05-19 US disclosed
US-5559230-A VASOPRESSIN ANTAGONISTS, QUINOLINES, BENZAZEPINES, VASODILATION, HYPOTENSIVE AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-09-24 US disclosed
EP-0450097-B1 BENZOHETEROCYCLIC COMPOUNDS OTSUKA PHARMA CO LTD (JP) 1996-04-24 EP disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0450097-A1 BENZOHETEROCYCLIC COMPOUNDS. OTSUKA PHARMA CO LTD (JP) 1991-10-09 EP disclosed
WO-1991005549-A1 BENZOHETEROCYCLIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-02 WO disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed